GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Unichem Laboratories Ltd (BOM:506690) » Definitions » EV-to-EBITDA

Unichem Laboratories (BOM:506690) EV-to-EBITDA : 15.89 (As of May. 25, 2025)


View and export this data going back to 1991. Start your Free Trial

What is Unichem Laboratories EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Unichem Laboratories's enterprise value is ₹48,584 Mil. Unichem Laboratories's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 was ₹3,058 Mil. Therefore, Unichem Laboratories's EV-to-EBITDA for today is 15.89.

The historical rank and industry rank for Unichem Laboratories's EV-to-EBITDA or its related term are showing as below:

BOM:506690' s EV-to-EBITDA Range Over the Past 10 Years
Min: -248.05   Med: 16.43   Max: 289.14
Current: 15.89

During the past 13 years, the highest EV-to-EBITDA of Unichem Laboratories was 289.14. The lowest was -248.05. And the median was 16.43.

BOM:506690's EV-to-EBITDA is ranked worse than
57.69% of 735 companies
in the Drug Manufacturers industry
Industry Median: 13.73 vs BOM:506690: 15.89

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2025-05-25), Unichem Laboratories's stock price is ₹642.15. Unichem Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was ₹21.320. Therefore, Unichem Laboratories's PE Ratio (TTM) for today is 30.12.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Unichem Laboratories EV-to-EBITDA Historical Data

The historical data trend for Unichem Laboratories's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Unichem Laboratories EV-to-EBITDA Chart

Unichem Laboratories Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.13 15.31 -46.37 58.08 17.37

Unichem Laboratories Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 58.08 50.46 37.53 45.37 17.37

Competitive Comparison of Unichem Laboratories's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Unichem Laboratories's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Unichem Laboratories's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Unichem Laboratories's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Unichem Laboratories's EV-to-EBITDA falls into.


;
;

Unichem Laboratories EV-to-EBITDA Calculation

Unichem Laboratories's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=48584.152/3057.688
=15.89

Unichem Laboratories's current Enterprise Value is ₹48,584 Mil.
Unichem Laboratories's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹3,058 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Unichem Laboratories  (BOM:506690) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Unichem Laboratories's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=642.15/21.320
=30.12

Unichem Laboratories's share price for today is ₹642.15.
Unichem Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹21.320.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Unichem Laboratories EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Unichem Laboratories's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Unichem Laboratories Business Description

Traded in Other Exchanges
Address
Off. S. V. Road, Unichem Bhavan, Prabhat Estate, Jogeshwari (West), Mumbai, MH, IND, 400 102
Unichem Laboratories Ltd is an India based pharmaceutical company. It manufactures a range of Active Pharmaceutical Ingredients (APIs). The company's products are offered in the areas of gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infectives and pain management. Some of its products include Apixaban, Brimonidine Tartrate, Finofibrate, Glipizide, Piroxicam and others. The company has a global market presence with sales in India and outside India, and the majority of the revenue derived from India. Its product categories comprises Formulations and Bulk Drugs and Chemicals.

Unichem Laboratories Headlines

No Headlines